PT UBC Medical Indonesia Tbk (IDX:LABS)

Market Cap	564.85B
Revenue (ttm)	169.80B
Net Income (ttm)	8.24B
Shares Out	3.95B
EPS (ttm)	2.09
PE Ratio	68.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,809,100
Average Volume	1,667,190
Open	142.00
Previous Close	142.00
Day's Range	135.00 - 144.00
52-Week Range	107.00 - 162.00
Beta	n/a
RSI	54.53
Earnings Date	Oct 28, 2025

About IDX:LABS

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 62
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2024, IDX:LABS's revenue was 147.64 billion, an increase of 8.00% compared to the previous year's 136.70 billion. Earnings were 2.95 billion, an increase of 34.84%.